PHK
ACET icon

Point72 Hong Kong’s Adicet Bio ACET Stock Holding History

Point72 Hong Kong’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-108
Closed -$18K – 1915
2021
Q2 		$18K Buy
+108
New +$22K ﹤0.01% 1654

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Point72 Hong Kong's ACET Position: Q3 2021 in Review

Point72 Hong Kong sold out of Adicet Bio (ACET) in Q3 2021, closing a stake of 108 shares — an estimated $18K sold.

Point72 Hong Kong first reported a position in ACET in Q2 2021 and held it in 1 quarter. The position peaked at $18K in Q2 2021. 58 funds tracked by Wall St. Rank hold ACET as of Q3 2021.

  • Point72 Hong Kong reported no remaining Adicet Bio position as of Q3 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 108 Adicet Bio shares in Q3 2021, an estimated $18K.
  • Point72 Hong Kong first reported a position in Adicet Bio in Q2 2021 and held it in 1 quarter.
  • Point72 Hong Kong's Adicet Bio position peaked at $18K in Q2 2021.
  • 58 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2021.

Based on Point72 Hong Kong's 13F filing for Q3 2021, filed 15 Nov 2021.